Sequana Medical N.V (2SE) Ratios
Sequana Medical N.V Ratios
DE:2SE's free cash flow for Q2 2025 was $-9.93M. For the 2025 fiscal year, DE:2SE's free cash flow was increased by $2.00 and operating cash flow was $-9.93M. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 23 | Dec 22 | Mar 22 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.12 | 0.32 | 1.52 | 1.80 | 2.25 |
| Quick Ratio | 0.08 | 0.21 | 1.35 | 1.50 | 2.01 |
| Cash Ratio | 0.07 | 0.13 | 1.25 | 1.34 | 1.85 |
| Solvency Ratio | -0.81 | -1.09 | -1.06 | -1.50 | -1.33 |
| Operating Cash Flow Ratio | -0.38 | -1.49 | -1.81 | -3.29 | -2.85 |
| Short-Term Operating Cash Flow Coverage | -0.51 | -3.72 | -6.13 | 9.36 | -64.49 |
| Net Current Asset Value | $ -47.91M | $ -23.27M | $ -5.09M | $ -2.60M | $ -659.26K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 4.03 | 1.73 | 0.68 | 0.55 | 0.55 |
| Debt-to-Equity Ratio | -0.90 | -0.90 | -8.17 | -10.27 | 69.70 |
| Debt-to-Capital Ratio | -9.40 | -9.01 | 1.14 | 1.11 | 0.99 |
| Long-Term Debt-to-Capital Ratio | 0.00 | -0.85 | 1.21 | 1.12 | 0.99 |
| Financial Leverage Ratio | -0.22 | -0.52 | -12.09 | -18.69 | 126.05 |
| Debt Service Coverage Ratio | -0.27 | -2.45 | -5.52 | 11.61 | -13.23 |
| Interest Coverage Ratio | -0.71 | -6.88 | -31.93 | -39.56 | -16.23 |
| Debt to Market Cap | 0.35 | 0.16 | 0.12 | 0.03 | 0.04 |
| Interest Debt Per Share | 1.82 | 0.81 | 0.81 | 0.48 | 0.58 |
| Net Debt to EBITDA | -2.09 | -0.51 | 0.04 | 0.07 | 0.18 |
| Profitability Margins | |||||
| Gross Profit Margin | -2092.45% | 76.95% | 77.83% | 79.31% | 78.99% |
| EBIT Margin | -16989.62% | -4141.05% | -3252.10% | -6116.60% | -1855.49% |
| EBITDA Margin | -16409.43% | -4091.26% | -3164.05% | -6002.90% | -1823.67% |
| Operating Profit Margin | -17647.17% | -4141.05% | -3044.86% | -6113.17% | -1811.99% |
| Pretax Profit Margin | -41861.32% | -4507.05% | -3292.17% | -6267.69% | -1967.15% |
| Net Profit Margin | -42126.42% | -4572.42% | -3334.08% | -6373.84% | -1983.45% |
| Continuous Operations Profit Margin | -42125.47% | -4572.42% | -3334.08% | -6373.84% | -1983.45% |
| Net Income Per EBT | 100.63% | 101.45% | 101.27% | 101.69% | 100.83% |
| EBT Per EBIT | 237.21% | 108.84% | 108.12% | 102.53% | 108.56% |
| Return on Assets (ROA) | -449.05% | -322.38% | -118.20% | -160.59% | -134.42% |
| Return on Equity (ROE) | 100.62% | 167.29% | 1428.68% | 3000.95% | -16943.83% |
| Return on Capital Employed (ROCE) | 43.23% | 314.93% | -258.29% | -300.98% | -211.64% |
| Return on Invested Capital (ROIC) | 540.85% | 2308.34% | -179.32% | -428.48% | -198.92% |
| Return on Tangible Assets | -449.05% | -322.38% | -118.20% | -160.59% | -134.42% |
| Earnings Yield | -39.87% | -30.41% | -22.52% | -17.15% | -10.58% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.35 | 16.53 | 2.27 | 0.97 | 2.86 |
| Payables Turnover | 0.01 | 0.06 | 0.06 | 0.03 | 0.10 |
| Inventory Turnover | 0.01 | 0.07 | 0.08 | 0.04 | 0.14 |
| Fixed Asset Turnover | 0.06 | 0.31 | 0.45 | 0.29 | 1.37 |
| Asset Turnover | 0.01 | 0.07 | 0.04 | 0.03 | 0.07 |
| Working Capital Turnover Ratio | -0.00 | -0.27 | 0.14 | 0.06 | 0.18 |
| Cash Conversion Cycle | 3204.19 | -958.55 | -920.58 | 122.83 | -848.73 |
| Days of Sales Outstanding | 1037.08 | 22.08 | 160.69 | 377.44 | 127.78 |
| Days of Inventory Outstanding | 28241.50 | 5105.41 | 4676.20 | 10186.01 | 2653.78 |
| Days of Payables Outstanding | 26074.39 | 6086.04 | 5757.47 | 10440.62 | 3630.29 |
| Operating Cycle | 29278.58 | 5127.49 | 4836.89 | 10563.45 | 2781.56 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.56 | -1.09 | -1.21 | -1.30 | -1.11 |
| Free Cash Flow Per Share | -0.56 | -1.11 | -1.24 | -1.31 | -1.12 |
| Dividend Paid and CapEx Coverage Ratio | -214.95 | -40.89 | -40.61 | -72.49 | -123.21 |
| Capital Expenditure Coverage Ratio | -214.95 | -40.89 | -40.61 | -72.49 | -123.21 |
| Operating Cash Flow Coverage Ratio | -0.51 | -1.66 | -1.56 | -2.92 | -2.16 |
| Operating Cash Flow to Sales Ratio | -192.64 | -40.81 | -29.78 | -63.74 | -17.65 |
| Free Cash Flow Yield | -18.32% | -27.80% | -20.61% | -17.39% | -9.49% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.51 | -3.29 | -4.44 | -5.83 | -9.46 |
| Price-to-Sales (P/S) Ratio | 1056.61 | 150.38 | 148.06 | 371.63 | 187.55 |
| Price-to-Book (P/B) Ratio | -2.52 | -5.50 | -63.45 | -174.97 | 1602.13 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.46 | -3.60 | -4.85 | -5.75 | -10.54 |
| Price-to-Operating Cash Flow Ratio | -5.48 | -3.68 | -4.97 | -5.83 | -10.62 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.34 | -1.15 | -1.46 | -3.85 |
| Enterprise Value Multiple | -8.53 | -4.19 | -4.64 | -6.12 | -10.10 |
| Enterprise Value | 148.31M | 122.03M | 135.33M | 136.17M | 177.50M |
| EV to EBITDA | -8.53 | -4.19 | -4.64 | -6.12 | -10.10 |
| EV to Sales | 1399.10 | 171.35 | 146.67 | 367.54 | 184.27 |
| EV to Free Cash Flow | -7.23 | -4.10 | -4.81 | -5.69 | -10.35 |
| EV to Operating Cash Flow | -7.26 | -4.20 | -4.92 | -5.77 | -10.44 |
| Tangible Book Value Per Share | -1.21 | -0.73 | -0.09 | -0.04 | 0.01 |
| Shareholders’ Equity Per Share | -1.21 | -0.73 | -0.09 | -0.04 | 0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| Revenue Per Share | 0.00 | 0.03 | 0.04 | 0.02 | 0.06 |
| Net Income Per Share | -1.22 | -1.22 | -1.35 | -1.30 | -1.25 |
| Tax Burden | 1.01 | 1.01 | 1.01 | 1.02 | 1.01 |
| Interest Burden | 2.46 | 1.09 | 1.01 | 1.02 | 1.06 |
| Research & Development to Revenue | 15.88 | 7.41 | 8.35 | 16.57 | 1.93 |
| SG&A to Revenue | 155.55 | 9.75 | 7.25 | 13.76 | 4.58 |
| Stock-Based Compensation to Revenue | -1.69 | 0.79 | 0.61 | 1.45 | 0.27 |
| Income Quality | 0.46 | 0.89 | 0.89 | 1.00 | 0.89 |
Currency in EUR